Oruka Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-18.8M | $-18.8M | $43.0K | $497.0K |
| FY2022 | $-10.9M | $-10.9M | $2.0K | $556.0K |
| FY2023 | $-5.0M | $-5.0M | $0 | $686.0K |
| FY2024 | $-57.8M | $-58.0M | $189.0K | $14.9M |
| FY2025 | $-88.2M | $-88.4M | $209.0K | $24.2M |